TW200502222A - Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders - Google Patents

Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Info

Publication number
TW200502222A
TW200502222A TW093108936A TW93108936A TW200502222A TW 200502222 A TW200502222 A TW 200502222A TW 093108936 A TW093108936 A TW 093108936A TW 93108936 A TW93108936 A TW 93108936A TW 200502222 A TW200502222 A TW 200502222A
Authority
TW
Taiwan
Prior art keywords
treatment
affective disorders
compound
dihydrocarbamazepine
hydroxy
Prior art date
Application number
TW093108936A
Other languages
English (en)
Inventor
Ferenc Martenyi
Markus Schmutz
Stefanie Zechner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200502222A publication Critical patent/TW200502222A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TW093108936A 2003-04-02 2004-03-31 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders TW200502222A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45986403P 2003-04-02 2003-04-02

Publications (1)

Publication Number Publication Date
TW200502222A true TW200502222A (en) 2005-01-16

Family

ID=33131906

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108936A TW200502222A (en) 2003-04-02 2004-03-31 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Country Status (18)

Country Link
US (1) US20070010508A1 (zh)
EP (1) EP1613329A1 (zh)
JP (1) JP2006522064A (zh)
KR (1) KR20050121235A (zh)
CN (1) CN1767834A (zh)
AU (1) AU2004226827B2 (zh)
BR (1) BRPI0409151A (zh)
CA (1) CA2520828A1 (zh)
IS (1) IS8094A (zh)
MA (1) MA27762A1 (zh)
MX (1) MXPA05010614A (zh)
NO (1) NO20055098L (zh)
NZ (1) NZ542555A (zh)
RU (1) RU2367440C2 (zh)
TN (1) TNSN05246A1 (zh)
TW (1) TW200502222A (zh)
WO (1) WO2004087168A1 (zh)
ZA (1) ZA200507742B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007013882A (es) * 2005-05-06 2008-01-28 Portela & Ca Sa Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
EP2386303A1 (en) * 2005-05-06 2011-11-16 Bial-Portela & CA, S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
GB2437078A (en) * 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
PT2254598E (pt) * 2008-02-13 2013-10-16 Targacept Inc Combinação de agonistas nicotínicos alfa 7 e antipsicóticos
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US8680050B2 (en) 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
CN102348715B (zh) 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CN102188432B (zh) * 2011-04-07 2012-05-23 江立富 一种用于防治癫痫的药物
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
US9896451B2 (en) 2013-09-06 2018-02-20 Nippon Soda Co., Ltd. Method for producing endo-9-azabicyclo[3.3.1]nonan-3-ol derivative
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE10036289A1 (de) 2000-07-26 2002-02-07 Bosch Gmbh Robert Elektronisch kommutierte elektrische Maschine, insbesondere Motor
EP1446383B1 (en) * 2001-11-12 2008-09-17 Novartis AG Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain

Also Published As

Publication number Publication date
EP1613329A1 (en) 2006-01-11
CA2520828A1 (en) 2004-10-14
NZ542555A (en) 2009-03-31
JP2006522064A (ja) 2006-09-28
KR20050121235A (ko) 2005-12-26
RU2005133665A (ru) 2006-06-10
NO20055098L (no) 2005-12-22
NO20055098D0 (no) 2005-11-01
MA27762A1 (fr) 2006-02-01
WO2004087168A1 (en) 2004-10-14
ZA200507742B (en) 2008-07-30
MXPA05010614A (es) 2005-11-23
TNSN05246A1 (en) 2007-06-11
AU2004226827A1 (en) 2004-10-14
US20070010508A1 (en) 2007-01-11
AU2004226827B2 (en) 2008-04-03
RU2367440C2 (ru) 2009-09-20
IS8094A (is) 2005-10-27
CN1767834A (zh) 2006-05-03
BRPI0409151A (pt) 2006-03-28

Similar Documents

Publication Publication Date Title
TNSN05246A1 (en) Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
MXPA04012998A (es) Modulares de receptores nucleares de hormonas esteroideas triciclicos.
CA2427227A1 (en) Lactam compound
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
TW200642685A (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
YU95102A (sh) Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija
SE0302760D0 (sv) New compounds
IL176107A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
MXPA04003245A (es) Hidroxipropilaminas.
MXPA03010843A (es) Uso de derivados con azetidinona en el tratamiento de enfermedad de alzheimer.
HUP0103781A2 (hu) Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák
SE9901573D0 (sv) New compounds
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
HUP0100024A2 (hu) Alzheimer-kór kezelésére szolgáló hatóanyagként karvedilolszármazékokat tartalmazó gyógyszerkészítmények
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
RS44004A (en) Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose